Page 2 - Ahammune Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ahammune biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ahammune Biosciences Today - Breaking & Trending Today

Ahammune Biosciences, Veeda conduct human studies for vitiligo drug

The preliminary research for AB1001 was conducted at Ahammune’s R&D laboratory based out of Pune ....

Parul Ganju , Ahammune Biosciences , Veeda Clinical Research , Ahammune Biosciences Veeda Clinical Research , Ahammune Biosciences Private , Pune Based Ahammune Biosciences , Ahmedabad Based Veeda Clinical Research , Executive Director , Ahammune Biosciences Private Limited , Veeda Clinical Research ,

Ahammune Biosciences, Veeda Clinical Research conduct human studies for vitiligo drug

The preliminary research for AB1001 was conducted at Ahammune’s R&D laboratory based out of Pune ....

Ahammune Biosciences , Ahammune Biosciences Veeda Clinical Research , Veeda Clinical Research , Pune Based Ahammune Biosciences , Ahmedabad Based Veeda Clinical Research , Veeda Clinical Research ,

2022 will see several quality companies in health sciences getting listed

Trends in Health sciences in 2021 & Prognosis for 2022
....

Samarskaya Oblast , Ma Pharmeasy Thyrocare , Ahammune Biosciences , Zumutor Biologics , Glenmark Lifesciences , Pharmaceuticals Emcure Nutrition Hexagon , Intox Pvt Ltd , Advent International , Pharmacy Health Aggregators , Pharmaceuticals Healthcare Services , Carlyle Group , Candle Partners , Private Equity Investors , Pristyn Care , Hong Kong Based , Samara Capital , Vikram Hospital , Vemgal Karnataka , Tata Cap , Atulaya Healthcare , Morgan Stanley , Sterling Accuris , Orange Diagnostics , Score Diagnostics , Vijaya Diagnostics , Max Healthcare ,

Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug

Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug
Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug
26 April 2021 | News
The fresh funds raised will be utilized for “first-in-human” studies with Ahammune’s new drug candidate AB1001 for vitiligo
Image credit- shutterstock.com
Pune-based biotech startup company, Ahammune Biosciences has raised an undisclosed amount in a Pre-Series A round led by Ideaspring Capital and Indian Angel Network. Kotak Private Equity, Legacy Assets LLP (Baldota family fund), and Dr. Ajith Kamath (ex-Pfizer) have also participated in the round along with existing investors, including Dr. Anand Deshpande and Suman Kant Munjal. The Company also has Dr. Ganesh Natarajan as an existing investor and has been in receipt of funding grant from Government of India’s body, BIRAC. ....

Suman Kant Munjal , Parul Ganju , Ganesh Natarajan , Anand Deshpande , Ahammune Biosciences , Ajith Kamath , Legacy Assets , Indian Angel Network , Ideaspring Capital , Indian Angel , Kotak Private Equity , Suman Kant , Investigational New Drug , Drug Controller General , சுமன் காந்த் முஞ்சல் , கணேஷ் நடராஜன் , ஆனந்த் தேஷ்பாண்டே , அஜீத் காமத் , மரபு சொத்துக்கள் , இந்தியன் தேவதை வலைப்பின்னல் , இந்தியன் தேவதை , கோட்டக் ப்ரைவேட் பங்கு , சுமன் காந்த் , மருந்து கட்டுப்படுத்தி ஜநரல் ,